Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence
1. DGX Q1 2025 sales reached $2.65 billion, up 12.1% YoY. 2. Adjusted earnings per share increased 8.3%, beating consensus estimates. 3. Company reaffirmed 2025 revenue and EPS guidance amidst strong demand. 4. Significant acquisitions and improved margins contributed to positive growth. 5. Analysts maintain Outperform rating, projecting resilience against economic challenges.